Rg3 can restore endothelial dysfunction against cardiotoxicity by inhibiting oxidative damage and apoptosis via Akt-mediated activation of the NF-E2-related factor 2-antioxidant response element (Nrf2-ARE) pathway injured by adriamycin (Wang et al., 2015). The gene discussed is NFE2L2; the disease is endothelial dysfunction.